BP665 0.5 mg (Tacrolimus 0.5 mg)
Pill with imprint BP665 0.5 mg is Yellow, Capsule-shape and has been identified as Tacrolimus 0.5 mg. It is supplied by Belcher Pharmaceuticals, LLC.
Tacrolimus is used in the treatment of organ transplant, rejection reversal; organ transplant, rejection prophylaxis and belongs to the drug class calcineurin inhibitors. Risk cannot be ruled out during pregnancy. Tacrolimus 0.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for BP665 0.5 mg
Tacrolimus
- Imprint
- BP665 0.5 mg
- Strength
- 0.5 mg
- Color
- Yellow
- Size
- 14.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Calcineurin inhibitors
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Belcher Pharmaceuticals, LLC
- National Drug Code (NDC)
- 62250-0665
- Inactive Ingredients
-
lactose anhydrous,
hypromellose 2208 (100 mPa.s),
croscarmellose sodium,
magnesium stearate,
gelatin,
titanium dioxide,
ferric oxide yellow,
shellac,
ferric oxide red,
dimethicone,
hydrated silica
Note: Inactive ingredients may vary.
More about tacrolimus
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Pricing & Coupons
- En Español
- 43 Reviews
- Drug class: calcineurin inhibitors
- FDA Alerts (1)
Consumer resources
- Patient Information
- Tacrolimus Intravenous (Advanced Reading)
- Tacrolimus Oral, Intravenous (Advanced Reading)
- Tacrolimus Extended-Release Tablets
- Tacrolimus Capsules
- ... +3 more
- Other brands
- Prograf, Envarsus XR, Astagraf XL, Hecoria
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.